Pelago is a virtual clinic for substance use management, delivering physician-led, evidence-based care for tobacco, alcohol, opioid and other substance use. Founded in 2017 as Quit Genius by three Imperial College London physicians, the company combines cognitive behavioral therapy, medication-assisted treatment and at-home monitoring tools into a program sold to employers, health plans and pharmacy benefit managers. Pelago says it has supported more than 750,000 members and validates its approach with 13 peer-reviewed studies.
Ria Health is a San Francisco-based telehealth company that treats alcohol use disorder entirely online. Founded in 2015 by addiction physician Dr. John Mendelson, it combines FDA-approved anti-craving medications (including naltrexone and The Sinclair Method), recovery coaching, digital progress tracking and a smartphone breathalyzer into a physician-managed program available in all 50 states. Ria treats drinking as a medical condition rather than a moral failing, offering flexible goals from moderation to abstinence, with care reimbursed by major insurers.
Recover is a San Diego-based, tech-enabled substance use treatment provider that combines medication-assisted treatment with counseling delivered via telehealth. Founded in 2021 by Nick Gulino and a former McKinsey team out of Y Combinator's Winter 2021 batch, the company partners with state and local governments to offer same-day, no-waitlist addiction care - in-network with Medi-Cal and certified by California's Department of Health Care Services - at roughly a tenth of the cost of traditional rehab facilities.
Ophelia is a New York-based telehealth company making evidence-based opioid use disorder (OUD) treatment available from home. It connects people to licensed clinicians for medication-assisted treatment (buprenorphine/Suboxone), with video visits, on-demand messaging, and care coordination, deliberately removing the friction and stigma of traditional rehab. Founded in 2019 by Zack Gray after he lost a loved one to an overdose, Ophelia focuses heavily on Medicaid and rural populations and has raised roughly $68 million, including a $50M Series B led by Tiger Global in 2021.